STOCK TITAN
  1. Home
  2. Sec-filings
  3. cbio
  4. [EFFECT] CRESCENT BIOPHARMA, INC. SEC Filing

[EFFECT] CRESCENT BIOPHARMA, INC. SEC Filing

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
EFFECT

Rhea-AI Filing Summary

Analyzing...
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: January 15, 2026 4:30 P.M.
Form: S-1
CIK: 0001253689
Company Name: CRESCENT BIOPHARMA, INC.
File Number: 333-292600

Source: View Original Filing on SEC EDGAR

Stock CBIO logo
Crescent Biopharma Inc

NASDAQ:CBIO

CBIO Rankings

#3745 Ranked by Market Cap
N/A Ranked by Dividends

CBIO Latest News

Feb 26, 2026
Crescent Biopharma Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights
Feb 23, 2026
Crescent Biopharma to Present at March Investor Conferences
Feb 19, 2026
Crescent Biopharma Announces Grants of Inducement Awards
Feb 18, 2026
Crescent Biopharma Announces First Patient Dosed in ASCEND Phase 1/2 Clinical Trial of CR-001 for the Treatment of Advanced Solid Tumors
Feb 5, 2026
Crescent Biopharma to Present at the Guggenheim Emerging Outlook: Biotech Summit 2026

CBIO Latest SEC Filings

Feb 26, 2026
[424B3] CRESCENT BIOPHARMA, INC. Prospectus Filed Pursuant to Rule 424(b)(3)
Feb 26, 2026
[8-K] CRESCENT BIOPHARMA, INC. Reports Material Event
Feb 26, 2026
[10-K] CRESCENT BIOPHARMA, INC. Files Annual Report
Feb 17, 2026
[SCHEDULE 13G/A] CRESCENT BIOPHARMA, INC. Amended Passive Investment Disclosure
Feb 17, 2026
[SCHEDULE 13G] CRESCENT BIOPHARMA, INC. Passive Investment Disclosure (>5%)

CBIO Stock Data

385.15M
25.47M
Biotechnology
Pharmaceutical Preparations
Link
United States
WALTHAM